Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
39.57
-0.57 (-1.42%)
Nov 21, 2024, 2:39 PM EST - Market open

Legend Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Jan '20 2019 - 2018
Market Capitalization
7,25910,9388,3577,1753,735-
Upgrade
Market Cap Growth
-26.66%30.89%16.46%92.11%--
Upgrade
Enterprise Value
6,4989,8357,6956,6133,163-
Upgrade
Last Close Price
40.1460.1749.9246.6128.16-
Upgrade
PS Ratio
14.0838.3671.42104.2549.80-
Upgrade
PB Ratio
6.608.7411.239.376.25-
Upgrade
P/TBV Ratio
8.068.7711.289.436.28-
Upgrade
EV/Sales Ratio
12.4934.4965.7696.0842.17-
Upgrade
Debt / Equity Ratio
0.310.260.380.160.010.04
Upgrade
Asset Turnover
0.290.180.100.070.150.17
Upgrade
Inventory Turnover
29.2535.3566.27176.58157.02-
Upgrade
Quick Ratio
4.866.773.594.115.092.00
Upgrade
Current Ratio
4.986.923.694.145.142.25
Upgrade
Return on Equity (ROE)
-28.35%-51.94%-59.11%-59.19%-71.12%-127.01%
Upgrade
Return on Assets (ROA)
-12.28%-17.39%-23.37%-26.75%-28.32%-22.95%
Upgrade
Return on Capital (ROIC)
-14.06%-21.19%-29.86%-33.05%-37.86%-97.08%
Upgrade
Earnings Yield
-4.75%-4.74%-5.34%-5.62%-7.13%-
Upgrade
FCF Yield
-2.37%-3.78%-2.66%-3.35%-6.67%-
Upgrade
Buyback Yield / Dilution
-6.16%-10.71%-12.91%-19.21%-18.15%-
Upgrade
Total Shareholder Return
-6.16%-10.71%-12.91%-19.21%-18.15%-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.